GREENMARK BIOMEDICAL INC.

Profile

Company Names

GREENMARK BIOMEDICAL INC.

Addresses

325 E. GRAND RIVER AVENUE, SUITE 314, EAST LANSING, MI 48823-4375

Phone Numbers

517-896-3665

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$1,700,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-10-14 
$500,000.00 
$1,000,000.00 
$500,000.00 
Debt 
1
2018-05-11 
$1,200,000.00 
$1,200,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVEN 
 
BLOEMBERGEN 
EXECUTIVE OFFICER, DIRECTOR
ECOSYNTHETIX INC   |  ECOSYNTHETIX INC.   |  GREENMARK BIOMEDICAL INC.
STEVEN 
 
BLOEMBERGEN, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
GREENMARK BIOMEDICAL INC.
JOERG 
 
LAHANN, PH.D. 
DIRECTOR
GREENMARK BIOMEDICAL INC.
KENNETH 
 
PIENTA, M.D. 
DIRECTOR
GREENMARK BIOMEDICAL INC.
MICHAEL 
 
SNYDER 
DIRECTOR
METAGENOMIX, INC.   |  BOSTON HEART LAB CORP   |  METABALL FITNESS SYSTEMS, LLC   |  BOSTON HEART DIAGNOSTICS CORP   |  SENSOMICS, INC.   |  CITRAPAC, INC.   |  LENDSTREET INC.   |  GREENMARK BIOMEDICAL INC.   |  STAR CATCHER INDUSTRIES INC.
MICHAEL 
D. 
SNYDER 
DIRECTOR
MDS 2012-MARCELLUS SHALE DEVELOPMENT, LP   |  MDS 2014-MARCELLUS SHALE DEVELOPMENT, LP   |  MDS ENERGY PARTNERS, LP   |  MDS 2017-MARCELLUS SHALE DEVELOPMENT, LP   |  GREENMARK BIOMEDICAL INC.   |  MDS 2018-MARCELLUS SHALE DEVELOPMENT, LP   |  MDS 2019-MARCELLUS SHALE DEVELOPMENT, LP   |  MDS 2020 - MARCELLUS SHALE DEVELOPMENT, LP   |  MDS 2021-MARCELLUS SHALE DEVELOPMENT, LP   |  MDS 2022-SHALE DEVELOPMENT, LP   |  KEYSTONE ENERGY FUND 2023 LP   |  KEYSTONE ENERGY FUND 2024 LP   |  MDS 2025-SHALE DEVELOPMENT, LP   |  KEYSTONE ENERGY FUND 2025 LP   |  MDS 2026-SHALE DEVELOPMENT, LP
FRANK 
 
VAN LUTTIKHUIZEN 
DIRECTOR
GREENMARK BIOMEDICAL INC.
FRANK 
 
VAN LUTTIKHUIZEN, CPA 
DIRECTOR
GREENMARK BIOMEDICAL INC.
JEFF 
 
WESLEY 
DIRECTOR
GREENMARK BIOMEDICAL INC.   |  ENSPIRED SOLUTIONS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-10-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-10-14 
2019-03-19
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-11 
2018-05-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#